Disease | cystoid macular dystrophy |
Comorbidity | C0154830|proliferative diabetic retinopathy |
Sentences | 16 |
PubMedID- 24707168 | Patients were divided into three groups: mild–moderate nonproliferative diabetic retinopathy without macular edema (npdr), mild–moderate nonproliferative diabetic retinopathy with macular edema (dme), and proliferative diabetic retinopathy (pdr). |
PubMedID- 24348012 | Fundus examination of the right eye showed nonproliferative diabetic retinopathy with macular edema and a swollen optic disk. |
PubMedID- 23792485 | Purpose: to evaluate the predictive value of microaneurysm (ma) formation rate concerning the development of clinically significant macular edema (csme) in patients with mild-to-moderate nonproliferative diabetic retinopathy as evaluated by an automated analysis of central field fundus 30 degrees photographs. |
PubMedID- 24363502 | Suggested that hba1c and total cholesterol are the two most important risk factors associated with clinically significant macular edema (csme) in patients with nonproliferative diabetic retinopathy [63] whereas zoppini et al. |
PubMedID- 25389718 | Difluprednate ophthalmic emulsion 0.05% as adjunctive treatment to panretinal photocoagulation for proliferative diabetic retinopathy with clinically significant macular edema. |
PubMedID- 22224029 | The fundus exam showed severe bilateral nonproliferative diabetic retinopathy, with greater macular edema in the right eye compared to the left eye. |
PubMedID- 23961505 | Fundus examination revealed bilateral severe proliferative diabetic retinopathy with macular edema and grade 2 hypertensive retinopathy. |
PubMedID- 26315560 | One-year progression of diabetic subclinical macular edema in eyes with mild nonproliferative diabetic retinopathy: location of the increase in retinal thickness. |
PubMedID- 20936526 | Intravitreal bevacizumab for persistent macular edema with proliferative diabetic retinopathy. |
PubMedID- 22279402 | Posterior segment examination [figures 1 and 2] showed mild nonproliferative diabetic retinopathy without diabetic macular edema and a normal looking optic disc od with a small cup-to-disc (cd) ratio (0.1). |
PubMedID- 24978668 | Conclusion: we demonstrated a significantly reduced sensitivity in both nonproliferative diabetic retinopathy groups without diabetic macular edema compared with healthy controls; this reduction was greater in type 2 diabetic patients. |
PubMedID- 25613583 | Twenty (40 %) patients had severe non-proliferative diabetic retinopathy with mild macular edema, which is the most prevalent type among the cases group. |
PubMedID- 24843311 | All the patients had proliferative diabetic retinopathy with chronic macular edema. |
PubMedID- 20393241 | Materials and methods: an observational case-study which included 180 type 2 diabetic patients (180 eyes) of nonproliferative diabetic retinopathy (npdr) with clinically significant macular edema (csme). |
PubMedID- 22937513 | Aim: to determine the risk factors of clinically significant macular edema (csme) in patients with non-proliferative diabetic retinopathy (npdr) in a multi-ethnics malaysian population. |
PubMedID- 23204247 | Microaneurysm turnover at the macula predicts risk of development of clinically significant macular edema in persons with mild nonproliferative diabetic retinopathy. |
Page: 1